MarketPulse — Real-Time Financial News & Market Analysis

Class action lawsuit filed against Fermi Inc. alleging material misrepresentations in October 2025 IPO regarding Project Matador demand and financial viability disclosures.

Ultragenyx Pharmaceutical faces class action lawsuit for allegedly making false statements about setrusumab drug efficacy and safety, affecting investors who bought securities between August 2023 and December 2025.

F5 faces class action lawsuit alleging it misrepresented security capabilities and failed to disclose a major product breach affecting investors between October 2024-2025.

Kiltearn Partners fully exits Sealed Air stake amid sales headwinds. The divestment of 335,500 shares represents a complete liquidation as Sealed Air faces declining revenues.

Beyond popular SCHD, alternative dividend ETFs like VIG offer comparable yields with different sector allocations and growth exposure for dividend investors.

Vanguard cuts expense ratios on 53 funds, including major equity ETFs like VIG and VYM, with some international funds seeing larger reductions up to 10 basis points.

Tech earnings mixed with strong AI infrastructure gains. Anthropic secures $30B funding; robotaxi launches in Abu Dhabi. Regulatory scrutiny and energy concerns mount as AI expands.

Large-cap stocks rallied on strong earnings beats. Magna International led gainers with 26.81% gain after exceeding expectations and raising 2026 guidance.

REGL dividend ETF surges 200 basis points YTD by tracking mid-cap firms with 15+ years of uninterrupted dividend growth, offering income investors stability.

Investors increasingly scrutinize earnings quality as firms rely on non-operational income to support profits amid stretched valuations and slowing business growth.

Analog Devices offers attractive value with strong earnings growth, while Walmart's high valuation leaves little room for disappointment amid diverging semiconductor and retail market dynamics.

Nio reports first adjusted operating profit with strong sales growth, but battery-swapping infrastructure losses and lower margins than competitors remain challenges.

Large-cap tech stocks plummeted this week on earnings disappointments and weak guidance, with Pinterest down 21.73% and multiple others declining 18-24% amid profitability concerns.

uniQure faces securities lawsuit alleging misleading statements about AMT-130's FDA pathway. Stock dropped 49% after FDA reversed stance. Investors have April deadline for lead plaintiff claims.

Fermi Inc. faces securities lawsuit after major tenant canceled $150M funding deal, causing 52% stock decline. Investors must file claims by March 6.

Beyond Meat faces securities lawsuit over delayed disclosure of $77.4M asset impairment charges, causing stock decline. Investors with losses exceeding $75K may join litigation.

Hub Group restates financials after discovering $77M accounting error in transportation costs. Stock dropped 25%, though cash flow unaffected.

Klarna faces securities lawsuit alleging IPO misstatements about loan loss reserves. Investors have until February 20 to join class action.

Wealthfront's stock plummets 26% after disappointing earnings. Legal investigation launched over weak asset inflows and CEO conflict-of-interest concerns regarding banking partner stake.

Aquestive Therapeutics' stock plunged 40% after FDA cited major deficiencies in its Anaphylm anaphylaxis treatment application. Shareholder lawsuit investigation underway over disclosure adequacy.